AVEPOINT INC (AVPT)
US0536041041 - Common Stock
We assign a fundamental rating of 5 out of 10 to AVPT. AVPT was compared to 284 industry peers in the Software industry. AVPT has a great financial health rating, but its profitability evaluates not so good. AVPT is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
AVPT had positive earnings in the past year.
In the past year AVPT had a positive cash flow from operations.
In the past 5 years AVPT always reported negative net income.
In multiple years AVPT reported negative operating cash flow during the last 5 years.
1.2 Ratios
AVPT has a Return On Assets (-1.65%) which is in line with its industry peers.
AVPT's Return On Equity of -3.57% is in line compared to the rest of the industry. AVPT outperforms 58.78% of its industry peers.
AVPT's Return On Invested Capital of 0.94% is fine compared to the rest of the industry. AVPT outperforms 64.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.65% | ||
| ROE | -3.57% | ||
| ROIC | 0.94% |
ROA(3y)-10.81%
ROA(5y)-38.58%
ROE(3y)-18.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 1.01%, AVPT is in the better half of the industry, outperforming 63.44% of the companies in the same industry.
AVPT has a Gross Margin of 74.61%. This is in the better half of the industry: AVPT outperforms 65.59% of its industry peers.
In the last couple of years the Gross Margin of AVPT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.01% | ||
| PM (TTM) | N/A | ||
| GM | 74.61% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y0.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AVPT is destroying value.
The number of shares outstanding for AVPT has been reduced compared to 1 year ago.
AVPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 7.09 indicates that AVPT is not in any danger for bankruptcy at the moment.
AVPT has a Altman-Z score of 7.09. This is in the better half of the industry: AVPT outperforms 73.84% of its industry peers.
AVPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 7.09 |
ROIC/WACC0.08
WACC11.43%
2.3 Liquidity
AVPT has a Current Ratio of 1.75. This is a normal value and indicates that AVPT is financially healthy and should not expect problems in meeting its short term obligations.
AVPT's Current ratio of 1.75 is in line compared to the rest of the industry. AVPT outperforms 51.25% of its industry peers.
A Quick Ratio of 1.75 indicates that AVPT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.75, AVPT is in line with its industry, outperforming 52.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.75 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
AVPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 412.50%, which is quite impressive.
AVPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.13%.
AVPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.43% yearly.
EPS 1Y (TTM)412.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)21.13%
Revenue growth 3Y21.51%
Revenue growth 5Y20.43%
Sales Q2Q%22.05%
3.2 Future
The Earnings Per Share is expected to grow by 66.07% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 20.75% on average over the next years. This is a very strong growth
EPS Next Y135.18%
EPS Next 2Y84.65%
EPS Next 3Y66.07%
EPS Next 5YN/A
Revenue Next Year22.5%
Revenue Next 2Y20.38%
Revenue Next 3Y19.63%
Revenue Next 5Y20.75%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 110.33, which means the current valuation is very expensive for AVPT.
AVPT's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.28, AVPT is valued quite expensively.
With a Price/Forward Earnings ratio of 69.34, AVPT can be considered very expensive at the moment.
AVPT's Price/Forward Earnings is on the same level as the industry average.
AVPT is valuated expensively when we compare the Price/Forward Earnings ratio to 23.53, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.33 | ||
| Fwd PE | 69.34 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as AVPT.
69.18% of the companies in the same industry are more expensive than AVPT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.58 | ||
| EV/EBITDA | 337.33 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AVPT's earnings are expected to grow with 66.07% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y84.65%
EPS Next 3Y66.07%
5. Dividend
5.1 Amount
AVPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AVEPOINT INC
NASDAQ:AVPT (1/14/2025, 8:24:49 PM)
Premarket: 16.99 +0.44 (+2.66%)16.55
+0.25 (+1.53%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners46.51%
Inst Owner Change0%
Ins Owners36.19%
Ins Owner Change1.69%
Market Cap3.10B
Analysts80
Price Target17.17 (3.75%)
Short Float %5.21%
Short Ratio4.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-60.55%
Min EPS beat(2)-139.53%
Max EPS beat(2)18.43%
EPS beat(4)3
Avg EPS beat(4)44.27%
Min EPS beat(4)-139.53%
Max EPS beat(4)231.49%
EPS beat(8)5
Avg EPS beat(8)-56.3%
EPS beat(12)8
Avg EPS beat(12)-185.34%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.04%
Min Revenue beat(2)1.68%
Max Revenue beat(2)4.41%
Revenue beat(4)4
Avg Revenue beat(4)2.31%
Min Revenue beat(4)1.02%
Max Revenue beat(4)4.41%
Revenue beat(8)7
Avg Revenue beat(8)1.66%
Revenue beat(12)8
Avg Revenue beat(12)0.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)33.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)19.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 110.33 | ||
| Fwd PE | 69.34 | ||
| P/S | 9.82 | ||
| P/FCF | 41.58 | ||
| P/OCF | 40.02 | ||
| P/B | 14.51 | ||
| P/tB | 16.76 | ||
| EV/EBITDA | 337.33 |
EPS(TTM)0.15
EY0.91%
EPS(NY)0.24
Fwd EY1.44%
FCF(TTM)0.4
FCFY2.41%
OCF(TTM)0.41
OCFY2.5%
SpS1.68
BVpS1.14
TBVpS0.99
PEG (NY)0.82
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.65% | ||
| ROE | -3.57% | ||
| ROCE | 1.19% | ||
| ROIC | 0.94% | ||
| ROICexc | 13.79% | ||
| ROICexgc | N/A | ||
| OM | 1.01% | ||
| PM (TTM) | N/A | ||
| GM | 74.61% | ||
| FCFM | 23.63% |
ROA(3y)-10.81%
ROA(5y)-38.58%
ROE(3y)-18.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y0.06%
F-Score7
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 55.25% | ||
| Cap/Sales | 0.92% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 916.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.75 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 7.09 |
F-Score7
WACC11.43%
ROIC/WACC0.08
Cap/Depr(3y)117.74%
Cap/Depr(5y)110.46%
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)412.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y135.18%
EPS Next 2Y84.65%
EPS Next 3Y66.07%
EPS Next 5YN/A
Revenue 1Y (TTM)21.13%
Revenue growth 3Y21.51%
Revenue growth 5Y20.43%
Sales Q2Q%22.05%
Revenue Next Year22.5%
Revenue Next 2Y20.38%
Revenue Next 3Y19.63%
Revenue Next 5Y20.75%
EBIT growth 1Y113.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year142.01%
EBIT Next 3Y75.79%
EBIT Next 5YN/A
FCF growth 1Y3317.16%
FCF growth 3Y21.68%
FCF growth 5YN/A
OCF growth 1Y3575.26%
OCF growth 3Y21.97%
OCF growth 5YN/A